Detalhe da pesquisa
1.
Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial.
Gastric Cancer
; 25(3): 598-608, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050442
2.
Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia.
Haematologica
; 106(2): 565-573, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241846
3.
Protein-losing enteropathy in association with gastrointestinal IgM deposition in Waldenström macroglobulinaemia.
Br J Haematol
; 198(5): 801, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796502
4.
Risk Stratification in Multinodular Goiter: A Retrospective Review of Sonographic Features, Histopathological Results, and Cancer Risk.
Can Assoc Radiol J
; 68(4): 425-430, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28835334
5.
AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection.
BMC Cancer
; 16: 622, 2016 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515171
6.
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Lancet Oncol
; 16(8): 937-48, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26184520
7.
Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib.
J Transl Med
; 13: 57, 2015 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25889309
8.
Case Study: Diffuse Large B-Cell Lymphoma Arising in Ovarian Mature Cystic Teratoma.
Int J Gynecol Pathol
; 34(5): 459-64, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25996637
9.
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.
Lancet Oncol
; 13(10): 1055-62, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22959186
10.
Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Radiation Therapy: A Case Report and Review of the Literature.
Case Rep Oncol
; 16(1): 1528-1535, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38045431
11.
Fine needle aspiration cytology in symptomatic breast lesions: still an important diagnostic modality?
Breast J
; 18(2): 103-10, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22404050
12.
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma.
Cancer Cell
; 40(9): 939-956.e16, 2022 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985343
13.
A coincidence or a rare occurrence? A case of plasmablastic lymphoma of the small intestines following infliximab treatment for Crohn's disease.
Ann Hematol
; 95(1): 149-150, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26361950
14.
Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors.
Clin Cancer Res
; 27(10): 2723-2733, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33622704
15.
Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation.
Histopathology
; 57(1): 27-38, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20584089
16.
Initial presentation of Pulmonary Langerhans cell histiocytosis as recurrent spontaneous pneumothoraces.
Respir Med Case Rep
; 31: 101280, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33209579
17.
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results.
Leukemia
; 34(11): 2903-2913, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32733012
18.
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
Biochem J
; 409(2): 581-9, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17868033
19.
Impact and importance of a centralised review panel for lymphoma diagnostics in the WHO era: a single-centre experience.
J Clin Pathol
; 72(7): 506-509, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910823
20.
Analysis of Biomarkers and Association With Clinical Outcomes in Patients With Differentiated Thyroid Cancer: Subanalysis of the Sorafenib Phase III DECISION Trial.
Clin Cancer Res
; 25(24): 7370-7380, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558473